nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—SLC22A5—dilated cardiomyopathy	0.351	0.44	CbGaD
Norepinephrine—ADRB1—dilated cardiomyopathy	0.242	0.304	CbGaD
Norepinephrine—ADRB2—dilated cardiomyopathy	0.204	0.256	CbGaD
Norepinephrine—SLC22A5—Furosemide—dilated cardiomyopathy	0.0613	1	CbGbCtD
Norepinephrine—Isoetarine—ADRB1—dilated cardiomyopathy	0.000821	0.115	CrCbGaD
Norepinephrine—Isoetarine—ADRB2—dilated cardiomyopathy	0.00069	0.0968	CrCbGaD
Norepinephrine—Arbutamine—ADRB1—dilated cardiomyopathy	0.000653	0.0916	CrCbGaD
Norepinephrine—Salbutamol—ADRB1—dilated cardiomyopathy	0.000634	0.0889	CrCbGaD
Norepinephrine—Arbutamine—ADRB2—dilated cardiomyopathy	0.000549	0.077	CrCbGaD
Norepinephrine—Salbutamol—ADRB2—dilated cardiomyopathy	0.000533	0.0748	CrCbGaD
Norepinephrine—Dopamine—SLC22A5—dilated cardiomyopathy	0.000425	0.0596	CrCbGaD
Norepinephrine—Epinephrine—SLC22A5—dilated cardiomyopathy	0.000415	0.0582	CrCbGaD
Norepinephrine—Droxidopa—ADRB1—dilated cardiomyopathy	0.000375	0.0526	CrCbGaD
Norepinephrine—Isoprenaline—ADRB1—dilated cardiomyopathy	0.000341	0.0478	CrCbGaD
Norepinephrine—Droxidopa—ADRB2—dilated cardiomyopathy	0.000315	0.0442	CrCbGaD
Norepinephrine—Dopamine—ADRB1—dilated cardiomyopathy	0.000293	0.0412	CrCbGaD
Norepinephrine—Isoprenaline—ADRB2—dilated cardiomyopathy	0.000287	0.0402	CrCbGaD
Norepinephrine—Epinephrine—ADRB1—dilated cardiomyopathy	0.000286	0.0402	CrCbGaD
Norepinephrine—Epinephrine—TNF—dilated cardiomyopathy	0.000272	0.0381	CrCbGaD
Norepinephrine—Epinephrine—ADRB2—dilated cardiomyopathy	0.000241	0.0338	CrCbGaD
Norepinephrine—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.3e-05	0.000172	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2.3e-05	0.000172	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2.3e-05	0.000172	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.28e-05	0.00017	CbGpPWpGaD
Norepinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	2.25e-05	0.000168	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.24e-05	0.000168	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.24e-05	0.000168	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.23e-05	0.000166	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.23e-05	0.000166	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.22e-05	0.000166	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.21e-05	0.000165	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	2.2e-05	0.000164	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	2.18e-05	0.000163	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.17e-05	0.000162	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	2.17e-05	0.000162	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.17e-05	0.000162	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.14e-05	0.00016	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.14e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.13e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.12e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.11e-05	0.000158	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.1e-05	0.000157	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.09e-05	0.000156	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.09e-05	0.000156	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.09e-05	0.000156	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.09e-05	0.000156	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.07e-05	0.000154	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.06e-05	0.000154	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	2.06e-05	0.000154	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	2.04e-05	0.000153	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.03e-05	0.000152	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.03e-05	0.000151	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.02e-05	0.000151	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.02e-05	0.000151	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.01e-05	0.00015	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.01e-05	0.00015	CbGpPWpGaD
Norepinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	2e-05	0.000149	CbGpPWpGaD
Norepinephrine—PAH—Disease—EGFR—dilated cardiomyopathy	1.98e-05	0.000148	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.97e-05	0.000147	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.97e-05	0.000147	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.94e-05	0.000145	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.94e-05	0.000145	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.9e-05	0.000142	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.9e-05	0.000142	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.88e-05	0.00014	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.87e-05	0.00014	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.87e-05	0.00014	CbGpPWpGaD
Norepinephrine—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.86e-05	0.000139	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	1.85e-05	0.000138	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.85e-05	0.000138	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.84e-05	0.000138	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—GPX1—dilated cardiomyopathy	1.83e-05	0.000137	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.83e-05	0.000137	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.81e-05	0.000136	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.81e-05	0.000135	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.8e-05	0.000135	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	1.8e-05	0.000134	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.8e-05	0.000134	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.8e-05	0.000134	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.79e-05	0.000134	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—CD36—dilated cardiomyopathy	1.79e-05	0.000133	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.77e-05	0.000132	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.76e-05	0.000131	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.73e-05	0.000129	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.73e-05	0.000129	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.73e-05	0.000129	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.72e-05	0.000129	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.71e-05	0.000128	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.71e-05	0.000128	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.7e-05	0.000127	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.69e-05	0.000126	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.68e-05	0.000126	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	1.68e-05	0.000126	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.68e-05	0.000125	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.67e-05	0.000125	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.65e-05	0.000123	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	1.65e-05	0.000123	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.64e-05	0.000122	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.64e-05	0.000122	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.64e-05	0.000122	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.64e-05	0.000122	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.62e-05	0.000121	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.62e-05	0.000121	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.62e-05	0.000121	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.62e-05	0.000121	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—AGT—dilated cardiomyopathy	1.61e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.6e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.6e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.6e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.6e-05	0.00012	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.58e-05	0.000118	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.57e-05	0.000117	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.56e-05	0.000117	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.56e-05	0.000116	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.55e-05	0.000116	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.54e-05	0.000115	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.53e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.52e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.52e-05	0.000114	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.52e-05	0.000113	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.52e-05	0.000113	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.51e-05	0.000113	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.51e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.5e-05	0.000112	CbGpPWpGaD
Norepinephrine—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.5e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AGT—dilated cardiomyopathy	1.49e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.49e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.49e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.49e-05	0.000112	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.49e-05	0.000111	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	1.49e-05	0.000111	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.47e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.46e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.45e-05	0.000109	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.45e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.44e-05	0.000108	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.43e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.41e-05	0.000105	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.4e-05	0.000105	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.39e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	1.39e-05	0.000104	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.39e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.39e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.39e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.38e-05	0.000103	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.38e-05	0.000103	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.38e-05	0.000103	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	1.37e-05	0.000102	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.37e-05	0.000102	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	1.36e-05	0.000102	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.34e-05	0.0001	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.34e-05	9.99e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.33e-05	9.91e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.33e-05	9.91e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.32e-05	9.86e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.31e-05	9.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.3e-05	9.72e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.28e-05	9.56e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.27e-05	9.5e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.26e-05	9.42e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.26e-05	9.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.25e-05	9.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.24e-05	9.28e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.24e-05	9.26e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.23e-05	9.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.23e-05	9.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.23e-05	9.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.23e-05	9.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.21e-05	9.07e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.2e-05	8.99e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.2e-05	8.93e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.19e-05	8.92e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.18e-05	8.85e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.18e-05	8.82e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.17e-05	8.71e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	1.15e-05	8.6e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.15e-05	8.57e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.15e-05	8.56e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.14e-05	8.54e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.13e-05	8.43e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.13e-05	8.42e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.13e-05	8.42e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	1.12e-05	8.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	1.12e-05	8.36e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.11e-05	8.29e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.11e-05	8.27e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.1e-05	8.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	1.09e-05	8.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.09e-05	8.13e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	1.07e-05	8.01e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.06e-05	7.91e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	1.04e-05	7.8e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.04e-05	7.78e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.04e-05	7.75e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.03e-05	7.71e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.03e-05	7.67e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.02e-05	7.62e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.02e-05	7.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	1.02e-05	7.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.02e-05	7.6e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	1.01e-05	7.54e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1e-05	7.51e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1e-05	7.5e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.88e-06	7.38e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	9.82e-06	7.33e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	9.73e-06	7.27e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.67e-06	7.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.64e-06	7.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.51e-06	7.1e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.49e-06	7.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.47e-06	7.08e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	9.41e-06	7.03e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.36e-06	6.99e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	9.28e-06	6.93e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	9.2e-06	6.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	9.09e-06	6.79e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	9.08e-06	6.78e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.99e-06	6.71e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	8.87e-06	6.62e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	8.85e-06	6.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	8.79e-06	6.56e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.75e-06	6.54e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	8.67e-06	6.48e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.63e-06	6.44e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	8.59e-06	6.42e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	8.45e-06	6.32e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.43e-06	6.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.31e-06	6.21e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	8.21e-06	6.13e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	8.08e-06	6.03e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	7.97e-06	5.96e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.84e-06	5.86e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.83e-06	5.85e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	7.79e-06	5.82e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.72e-06	5.77e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	7.51e-06	5.61e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	7.45e-06	5.56e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	7.18e-06	5.36e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.14e-06	5.34e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—EGFR—dilated cardiomyopathy	7.11e-06	5.31e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.08e-06	5.29e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.99e-06	5.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	6.98e-06	5.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	6.75e-06	5.05e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	6.67e-06	4.98e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.61e-06	4.94e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.51e-06	4.86e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	6.15e-06	4.6e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	6.1e-06	4.56e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	6.02e-06	4.5e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	6e-06	4.48e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.78e-06	4.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	5.7e-06	4.25e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	5.61e-06	4.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.37e-06	4.01e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	5.17e-06	3.86e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	5.02e-06	3.75e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.98e-06	3.72e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	4.89e-06	3.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	4.63e-06	3.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.63e-06	3.46e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	4.4e-06	3.29e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.22e-06	3.15e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	4.18e-06	3.12e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.13e-06	3.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	3.91e-06	2.92e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	3.84e-06	2.87e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.54e-06	2.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.41e-06	2.55e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.17e-06	2.37e-05	CbGpPWpGaD
